Skip to content
About
Company Overview
Mission
Leadership
Science & Technology
Inflammation, Infection, & Tissue Injury
Zelpultide Alfa
Intellectual Property
Programs
Pipeline Overview
Bronchopulmonary dysplasia
Acute Respiratory Distress Syndrome (ARDS)
Pulmonary Fibrosis
Newsroom
Press Releases
In the Media
Resources
Clinical Trials Information
Publications & Presentations
Investor Resources
Careers
Contact Us
About
Company Overview
Mission
Leadership
Science & Technology
Inflammation, Infection, & Tissue Injury
Zelpultide Alfa
Intellectual Property
Programs
Pipeline Overview
Bronchopulmonary dysplasia
Acute Respiratory Distress Syndrome (ARDS)
Pulmonary Fibrosis
Newsroom
Press Releases
In the Media
Resources
Clinical Trials Information
Publications & Presentations
Investor Resources
Careers
Contact Us
Publications & Presentations
Zhang, L, et al. 2002. Reversibility of Pulmonary Abnormalities by Conditional Replacement of Surfactant Protein D (SP-D) in Vivo. The Journal of Biological Chemistry. Volume 277. Issue 41.
October 1, 2002
©2026 Airway Therapeutics, Inc. All Rights Reserved.
Privacy Policy
|
Terms of Use
|
Accessibility Statement
|
Cookie Preferences